BioMarin Pharmaceutical Inc. (LON: 0HNC)

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 23, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	9,597	14,259	15,963	11,979	11,659	11,467
Market Cap Growth	-26.82%	-10.67%	33.26%	2.74%	1.67%	-3.61%
Enterprise Value	9,331	14,235	15,811	11,985	11,659	11,609
Last Close Price	50.32	75.71	83.80	66.15	64.78	64.31
PE Ratio	39.91	108.34	135.87	-	18.64	-
PS Ratio	4.86	7.51	9.18	8.79	8.56	8.91
PB Ratio	2.47	3.67	4.18	3.80	3.88	4.86
P/TBV Ratio	2.70	4.10	4.73	4.41	4.56	6.15
P/FCF Ratio	41.83	290.28	350.06	77.63	-	-
P/OCF Ratio	32.27	114.04	109.34	53.26	186.47	314.68
EV/Sales Ratio	4.17	7.49	9.09	8.79	8.56	9.02
EV/EBITDA Ratio	26.08	65.58	111.45	481.22	1186.81	34707.47
EV/EBIT Ratio	35.21	105.36	276.25	-	-	-
EV/FCF Ratio	39.10	289.80	346.74	77.67	-	-
Debt / Equity Ratio	0.11	0.23	0.24	0.26	0.28	0.29
Debt / EBITDA Ratio	1.37	3.90	6.07	23.56	43.10	67.53
Debt / FCF Ratio	1.88	18.12	20.38	5.38	-	-
Asset Turnover	0.40	0.37	0.34	0.31	0.35	0.37
Inventory Turnover	1.19	1.26	1.36	1.49	1.67	1.77
Quick Ratio	2.39	1.45	2.98	2.54	3.07	1.21
Current Ratio	4.27	2.51	4.67	4.16	4.76	2.08
Return on Equity (ROE)	6.25%	3.51%	3.19%	-1.53%	23.63%	-0.78%
Return on Assets (ROA)	3.00%	1.63%	0.70%	-0.78%	-1.09%	-1.44%
Return on Capital (ROIC)	3.40%	1.82%	0.78%	-0.87%	-1.24%	-1.67%
Earnings Yield	2.51%	0.92%	0.74%	-0.40%	5.37%	-0.16%
FCF Yield	2.49%	0.34%	0.29%	1.29%	-0.18%	-0.64%
Buyback Yield / Dilution	-0.93%	-1.39%	-3.34%	4.60%	-7.06%	-1.00%
Total Shareholder Return	-0.93%	-1.39%	-3.34%	4.60%	-7.06%	-1.00%

Source: S&P Capital IQ. Standard template. Financial Sources.